South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and ...

If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO ...

GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million ...

Andelyn Biosciences and PQP Group have partnered to streamline cell and gene therapy supply to the EU and UK, integrating ...

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a ...

Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale ...

BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokohama, 7 to 9 October Forty years after its first edition in 1986, BioJapan opened its 2026 edition at PACIFICO Yokohama on ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US.

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...

Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment ...